Texas Health and Human Services [ [link removed] ]
Blue Gradient
Reminder: Changes in Hepatitis C Treatment Coverage for Medicaid Clients Begins Jan. 1
The Texas Health and Human Services Commission (HHSC) recently partnered [ [link removed] ] with AbbVie to work toward significantly reducing chronic Hepatitis C in Medicaid patients. HHSC will publish an update [ [link removed] ] to the Texas Medicaid Preferred Drug List (PDL) on Jan. 1 to designate preferred and non-preferred options for direct-acting antiviral (DAA) treatment.
Other news
* Younger Age Groups Now Eligible For Updated Bivalent COVID-19 Vaccines [ [link removed] ]
* Annual Review of Clinical Prior Authorization Criteria Guides to Begin; Changes Scheduled for Feb. 7 [ [link removed] ]
* Androgenic Agents Clinical Prior Authorization Revisions Scheduled for Feb. 1, 2023 [ [link removed] ]
* Semi-annual Medicaid Preferred Drug List Update Coming Jan. 26 [ [link removed] ]
________________________________________________________________________
You have subscribed to get updates about Texas Health and Human Services (HHS). For more information about HHS, please visit our website [ [link removed] ].
________________________________________________________________________
Stay Connected Visit us on Facebook [ [link removed] ] Visit us on YouTube [ [link removed] ] Visit us on Twitter [ [link removed] ] Visit us on Instagram [ [link removed] ] Visit us on Facebook [ [link removed] ] (en español)
Bookmark and Share [ [link removed] ]
Subscriber Services
Manage Preferences [ [link removed] ] | Unsubscribe [ [link removed] ] | Help [ [link removed] ]
________________________________________________________________________
This email was sent to
[email protected] using govDelivery Communications Cloud on behalf of: Texas Health and Human Services Commission · 707 17th St, Suite 4000 · Denver, CO 80202 GovDelivery logo [ [link removed] ]
